Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The green section shows the dosing phase where medication accumulates with each dose
+advitam: Personalized Medical Weight Loss +advitam provides personalized medical weight loss solutions, including GLP-1 therapy, tailored to each individuals needs
The 28g protein per serving provides approximately 2.7g leucine, the amino acid threshold required to maximally stimulate muscle protein synthesis in most athletes
Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect [PMID: 10499368] Laboratory literature summary: Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats
The STEP UP trial, published in The Lancet Diabetes & Endocrinology in September 2025, showed 18.7% average weight loss at 72 weeks compared to 15.6% at the standard 2.4 mg dose
In addition, human-interest senolytic dosing is typically pulsed/intermittent (a few consecutive days per cycle), so the continuous once-daily-for-16-weeks schedule shown here diverges from the typical senolytic paradigm and should be read as illustrative, not validated
